WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type 2 diabetes (T2D) and gout, new research has found. Data from a large US claims …

A drug used to treat gout might also be the key to helping patients taper off their opioid medication, or stop taking it altogether. University of Calgary researchers say when patients try to taper off their opioid medication, there is a part of their …

Mayen Jaymalin - The Philippine Star August 12, 2024 | 12:00am MANILA, Philippines — The Food and Drug Administration (FDA) has ordered the recall from the market of two lots of an anti-gout medicine, declaring that the lots did not have enough  active …

Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current treatments. For patients with gout who cannot get relief …

Drug firm Granules India on Tuesday said it has received approval from the US health regulator to market a medication used to prevent or treat gout attacks. Granules Pharmaceuticals, Inc, a wholly-owned foreign subsidiary of the company, has received …

New Delhi, Apr 30 (PTI) Drug firm Granules India on Tuesday said it has received approval from the US health regulator to market a medication used to prevent or treat gout attacks. Granules Pharmaceuticals, Inc, a wholly-owned foreign subsidiary of the …

The U.S. branch of India’s Sun Pharma issued a voluntary recall of more than 55,000 bottles of febuxostat tablets used to treat gout after a report of microbial contamination in the company's manufacturing facility. The Class II recall, which is what …

… 3 clinical trial for its gout drug candidate, URC102 (epaminurad). The phase …

… the woman allegedly killed with gout medication by her Mayo Clinic doctor …